Tag: Oral lichen planus

Oral lichenoid drug eruptions are an uncommon adverse reaction, and evidence from case reports and clinical reviews suggests that ramipril, an ACE inhibitor, can be a potential trigger. While the reaction is clinically and histopathologically similar to oral lichen planus (OLP), a key distinction is its correlation with medication use. Discontinuing the causative drug is the primary treatment, which often leads to resolution of the lesions.

Studies have shown that topical betamethasone, the active ingredient in Betnesol, is an effective treatment for minor and major recurrent aphthous stomatitis. This powerful corticosteroid is prepared as a mouthwash to deliver targeted relief, but understanding what is the use of Betnesol gargles and its proper administration is crucial for safety and efficacy.